G
Gary W. Donaldson
Researcher at University of Utah
Publications - 120
Citations - 5482
Gary W. Donaldson is an academic researcher from University of Utah. The author has contributed to research in topics: Randomized controlled trial & Chronic pain. The author has an hindex of 40, co-authored 115 publications receiving 5041 citations. Previous affiliations of Gary W. Donaldson include Fred Hutchinson Cancer Research Center & University of Washington.
Papers
More filters
Journal ArticleDOI
Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: a controlled clinical trial.
Karen L. Syrjala,Karen L. Syrjala,Gary W. Donaldson,Martha W. Davis,Michael E. Kippes,John E. Carr +5 more
TL;DR: It is concluded that relaxation and imagery training reduces cancer treatment‐related pain; adding cognitive‐behavioral skills to the relaxation with imagery does not, on average, further improve pain relief.
Journal ArticleDOI
A randomized clinical trial of home nursing care for lung cancer patients
Ruth McCorkle,Jeanne Quint Benoliel,Gary W. Donaldson,Fotini Georgiadou,Carol M. Moinpour,Brian W. Goodell +5 more
TL;DR: Home nursing care assists patients with forestalling distress from symptoms and maintaining their independence longer in comparison to no home nursing care, suggesting that home care may also include assisting patients in acknowledging the reality of their situation.
Journal ArticleDOI
Hypnosis or cognitive behavioral training for the reduction of pain and nausea during cancer treatment: a controlled clinical trial.
TL;DR: It is indicated that hypnosis was effective in reducing reported oral pain for patients undergoing marrow transplantation and risk, SIP, and BSI pre‐transplant were found to be effective predictors of inpatient physical symptoms.
Journal Article
Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial.
C. Collins,Janet F. Eary,Gary W. Donaldson,Cheryl B. Vernon,N. E. Bush,Stephen H. Petersdorf,Robert B. Livingston,E. E. Gordon,C. R. Chapman,Fred Appelbaum +9 more
TL;DR: Samarium-153-ethylenediaminetetramethylene phosphoric acid (EDTMP), a bone-seeking radiopharmaceutical, was given to prostate cancer patients in a dose escalation protocol for pain palliation to determine the maximally tolerated dose.
Journal ArticleDOI
Quality of life of 125 adults surviving 6–18 years after bone marrow transplantation
TL;DR: Almost all long-term survivors were leading full and meaningful lives, and demonstrated good mood and low psychological distress compared to cancer and population norms, and had the same perceptions as the general population of their current health and expectation of future health.